InBios
is a Washington-based biotechnology firm that develops and commercializes immunodiagnostic devices for infectious diseases and biothreats... Read moreInBios
is a Washington-based biotechnology firm that develops and commercializes immunodiagnostic devices for infectious diseases and biothreats... Read more
President
Estela Raychaudhuri
News
Sep 17, 2026
PRWeb
Press Release: InBios : InBios' Lyme Detect Multiplex ELISA Demonstrates Potential to Streamline Lyme Disease Testing in New UConn Health Study
Dec 04, 2024
The Business Journals
InBios: Seattle biotech company lands $16.5 million award for disease test
Dec 03, 2024
PRWeb
Press Release: InBios : Seattle's InBios Secures BARDA-funded Project Award Valued Over $16M to Enhance Rapid Biothreat Test
Sep 05, 2024
PRWeb
Press Release: InBios : InBios Receives FDA 510(k) Clearance for COVID-19 POC Antigen Detection Test
Aug 14, 2024
PRWeb
Press Release: InBios : InBios Launches an In Vitro Diagnostic Test for Strongyloidiasis Providing Fast Results
Mar 01, 2023
PRWeb
Press Release: InBios : FDA Grants First Marketing Rights for Anthrax Point-of-Care Test to InBios
Nov 15, 2022
PRWeb
Press Release: InBios : InBios Awarded Funding for Lyme Disease Diagnostic from HHS, Cohen Foundation
Nov 30, 2021
StreetInsider
Press Release: InBios : InBios Receives FDA EUA for Home Use Antigen Test for COVID-19
Oct 28, 2021
StreetInsider
Press Release: InBios : InBios Receives FDA EUA for COVID-19 Neutralizing Antibody ELISA
Sep 30, 2021
PR Newswire
Press Release: InBios : Curebase Solutions Supports Another InBios FDA Emergency Use Authorization for COVID-19 IgG Antibody Rapid Test
InBios Competitors
1
2
3
4
5
6
7
8
9
10